Cargando…

Adverse reaction signal detection methodology in pharmacoepidemiology

Detalles Bibliográficos
Autor principal:	Stricker, Bruno H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995985/ https://www.ncbi.nlm.nih.gov/pubmed/29869030 http://dx.doi.org/10.1007/s10654-018-0417-5

Ejemplares similares

Considering sex-specific adverse drug reactions should be a priority in pharmacovigilance and pharmacoepidemiological studies
por: Lapeyre-Mestre, Maryse
Publicado: (2019)

Pharmacoepidemiological considerations in observed‐to‐expected analyses for vaccines
por: Mahaux, Olivia, et al.
Publicado: (2015)

Cancer Pharmacogenomics and Pharmacoepidemiology: Setting a Research Agenda to Accelerate Translation
por: Freedman, Andrew N., et al.
Publicado: (2010)

Practice-Based Research Networks: Integrating Clinical Data for Improved Pharmacoepidemiology
por: Sousa-Veloso, Tiago
Publicado: (2016)

Real-World Evidence: Pharmacoepidemiology for Daily Clinical Practice—An Experience from Colombia
por: Machado-Alba, Jorge Enrique, et al.
Publicado: (2020)

Embracing Uncertainties Over the Evidence of New Oral Antivirals for COVID‐19: Challenges in Pharmacoepidemiologic Research
por: Ferreira da Silva, Renato, et al.
Publicado: (2023)

Pharmacovigilance and Pharmacoepidemiology
Publicado: (2008)

Understanding pharmacoepidemiology
Publicado: (2011)

Pharmacoepidemiology: An Overview
por: Sabaté, Mònica, et al.
Publicado: (2023)

Utilization of Pharmacokinetic/Pharmacodynamic Modeling in Pharmacoepidemiological Studies: A Systematic Review on Antiarrhythmic and Glucose-Lowering Medicines
por: Mohammadi Jouabadi, Soroush, et al.
Publicado: (2022)

A serious nightmare: psychiatric and neurologic adverse reactions to mefloquine are serious adverse reactions
por: Nevin, Remington L.
Publicado: (2017)

Strengthening standards, transparency, and collaboration to support medicine evaluation: Ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)
por: Kurz, Xavier, et al.
Publicado: (2018)

Children and ADRs (Adverse Drug Reactions)
por: Napoleone, Ettore
Publicado: (2010)

Adverse drug reaction reporting and development of pharmacovigilance systems in Bosnia and Herzegovina, Croatia, Serbia, and Montenegro: a retrospective pharmacoepidemiological study
por: Glamočlija, Una, et al.
Publicado: (2018)

The Promotion of Data Sharing in Pharmacoepidemiology
por: Sethi, Nayha
Publicado: (2014)

Editorial: Women in pharmacoepidemiology: 2021
por: Lopes, Luciane Cruz, et al.
Publicado: (2023)

The use of narrative electronic prescribing instructions in pharmacoepidemiology: A scoping review for the International Society for Pharmacoepidemiology
por: Romanelli, Robert J., et al.
Publicado: (2021)

Epidemiology and ‘big data’
por: Stricker, Bruno H.
Publicado: (2017)

Repeated interviews are much better for drug exposure assessment than a single baseline interview
por: Stricker, Bruno H.
Publicado: (2019)

Limitations and obstacles of the spontaneous adverse drugs reactions reporting: Two “challenging” case reports
por: Palleria, Caterina, et al.
Publicado: (2013)

The Challenges and Opportunities of Pharmacoepidemiology in Bone Diseases
por: Alarkawi, Dunia, et al.
Publicado: (2018)

Pharmacoepidemiological aspects of outpatient pain medication
por: Zebedin, Eva-Maria, et al.
Publicado: (2011)

Evaluation of Medication-mediated Effects in Pharmacoepidemiology
por: Tchetgen Tchetgen, Eric J., et al.
Publicado: (2017)

Women are started on a lower daily dose of metoprolol than men irrespective of dose recommendations: A potential source of confounding by contraindication in pharmacoepidemiology
por: Hendriksen, Linda C., et al.
Publicado: (2021)

Artificial Intelligence in Pharmacoepidemiology: A Systematic Review. Part 2–Comparison of the Performance of Artificial Intelligence and Traditional Pharmacoepidemiological Techniques
por: Sessa, Maurizio, et al.
Publicado: (2021)

The changing face of Australian data reforms: impact on pharmacoepidemiology research
por: de Oliveira Costa, Juliana, et al.
Publicado: (2021)

Drug exposure misclassification in pharmacoepidemiology: Sources and relative impact
por: Hempenius, Mirjam, et al.
Publicado: (2021)

All vials are not the same: Potential role of vaccine quality in vaccine adverse reactions
por: Bruce Yu, Yihua, et al.
Publicado: (2021)

Adverse drug reactions in the era of COVID-19
por: Cornelius, Angela P.
Publicado: (2021)

Pharmacoepidemiology in Japan: medical databases and research achievements
por: Tanaka, Shiro, et al.
Publicado: (2015)

Power calculator for instrumental variable analysis in pharmacoepidemiology
por: Walker, Venexia M, et al.
Publicado: (2017)

Targeted Maximum Likelihood Estimation for Pharmacoepidemiologic Research
por: Pang, Menglan, et al.
Publicado: (2016)

Quality of reporting of drug exposure in pharmacoepidemiological studies
por: Hempenius, Mirjam, et al.
Publicado: (2020)

43. A Pharmacoepidemiologic Evaluation of Echinocandin Use
por: Jo, Jinhee, et al.
Publicado: (2020)

Evaluation of Covid-19 vaccines: Pharmacoepidemiological aspects
por: Pariente, Antoine, et al.
Publicado: (2021)

Incidence in pharmacoepidemiology—Basic definitions and types of misclassification
por: Hoffmann, Mikael, et al.
Publicado: (2022)

Prediction Models for Adverse Pregnancy Outcomes in India: Methodological Considerations for an Emerging Topic
por: Pereira, Gavin
Publicado: (2022)

Longitudinal Methods for Modeling Exposures in Pharmacoepidemiologic Studies in Pregnancy
por: Wood, Mollie E, et al.
Publicado: (2021)

Legislation and current developments in adverse drug reaction reporting in Mongolia: how far are we?
por: Zulzaga, Zuzaan, et al.
Publicado: (2021)

Case-Only Designs in Pharmacoepidemiology: A Systematic Review
por: Nordmann, Sandra, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_c7740i6ms8k78hes608u9j29mp